血小板凝集デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

世界の血小板凝集デバイスの市場規模は、2023年に3億6,554万米ドル、2030年までに5億7,325万米ドルに達し、2024年～2030年の予測期間にCAGRで7.85％の成長が見込まれます。市場は、心血管疾患、血液疾患、その他の対象疾患の有病率の上昇や、世界の老年人口の負担の急増などのさまざまな要因によってプラス成長を示しています。さらに、血小板凝集計の技術の進歩、例えば、血小板の正確な自動検査などの進歩は、今後数年間にデバイスの需要を増加させます。さらに、医療産業における産学連携や臨床研究の増加も、血小板凝集デバイス市場の成長に寄与します。また、世界中で規制当局の承認や発売が増加していることも、血小板凝集デバイス市場全体の成長をさらに高めます。したがって、血小板凝集デバイス市場は、2024年～2030年の予測期間に大幅なCAGRで成長すると推定されます。

血小板凝集デバイスの市場力学

血小板凝集デバイス市場の主な促進要因の1つは、出血や血液疾患の増加です。

例えば、National Organization for Rare Disorders（NORD）は最新の調査で、米国における成人の免疫性血小板減少症（ITP）の罹患率は10万人あたり3.3人/年と推定されると述べています。また、ITPの有病率は10万人あたり9.5人と報告されています。さらに、メMaryland Health Care Commission（2023）の調査では、2022年の米国におけるITPの有病率は、1～5歳では10万人あたり9.5人、6～10歳では10万人あたり7.3人、11～14歳では10万人あたり4.1人と推定されています。

免疫性血小板減少症（ITP）は血小板障害の一種で、その診断は血小板凝集デバイスの助けを借りて行うことができます。したがって、ITPの数値の増加は診断検査を増加させ、最終的に血小板凝集デバイス市場の需要を上昇させます。

さらに、その他の出血や血小板障害の罹患率の増加が血小板凝集デバイス市場を牽引します。例えば、ベルナールスーリエ症候群は稀な出血性疾患で、男女同数が罹患します。NORDによる近年の研究では、ベルナールスーリエ症候群は100万人に1人の割合で発症するとされています。2022年に世界中で200例以上の症例が報告されています。このような症候群の発見は、血小板凝集デバイスを利用して行うことができます。

さらに、血小板凝集システムの需要は、主に血管表面と血小板の相互作用に関与するメカニズムを知るための調査研究や、抗血小板薬の新しい標的を知るための抗血栓因子の評価とスクリーニングの増加により、学術機関や製薬企業で増加しています。このように、研究開発活動や臨床試験の増加が、今後数年間の市場におけるデバイスの需要を促進します。

したがって、2024年～2030年の予測期間に上記の要因が総体的に血小板凝集デバイス市場全体を牽引します。

しかし、製品の入手可能性の低下や、訓練を受けた熟練した専門家の不足、処置の制限などが、世界の血小板凝集デバイス市場の成長を妨げる可能性があります。

COVID-19パンデミックは血小板凝集デバイス市場にマイナスの影響を与えています。パンデミックの発生により、外来受診がキャンセルされ、がん、糖尿病、心血管障害などの慢性疾患に対する緊急性のない病院や外科手術が中止されました。さらに、COVID-19検査が優先されたため、多くの疾患の診断検査が減少しました。さらに、厳しいロックダウン規制が課されたため、デバイスの製造が中止されました。しかし、COVID-19のワクチン開発は、ロックダウン規制の緩和と経済状況の正常化に伴う経済回復のプロセスを生み出し、さまざまな疾患の治療と管理に向けた定期的な医療サービス、診断検査、外科手術の再開のプロセスを開始し、結果として血小板凝集デバイス市場の需要を増加させ、血小板凝集デバイス市場におけるデバイスの需要を軌道に乗せました。

当レポートでは、世界の血小板凝集デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 血小板凝集デバイス市場レポートのイントロダクション

第2章 血小板凝集デバイス市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 血小板凝集デバイス市場の主な要因の分析

• 血小板凝集デバイス市場の促進要因
  • 心血管疾患、血液疾患、その他の対象疾患の有病率の上昇
  • 老年人口の負担の急増
  • 血小板凝集計の技術の進歩
  • 産学連携や臨床研究の増加
• 血小板凝集デバイス市場の抑制要因と課題
  • 製品の入手可能性の低下
  • 訓練を受けた熟練した専門家の不足
  • 処置の制限
• 血小板凝集デバイス市場の機会
  • 診断検査室における自動システムの採用と市場選好の高まり
  • ポイントオブケアおよび小型化された血小板凝集計の組み込み

第5章 血小板凝集デバイス市場のポーターのファイブフォース分析

第6章 血小板凝集デバイス市場に対するCOVID-19の影響分析

第7章 血小板凝集デバイス市場のレイアウト

• 製品タイプ別
  • システム
  • 試薬
  • 消耗品、付属品
• 用途別
  • 臨床用途
  • 研究用途
• エンドユーザー別
  • 病院
  • 診断研究所
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 血小板凝集デバイス市場：世界の企業シェア分析 - 主要3～5社

第9章 血小板凝集デバイス市場の企業と製品のプロファイル

• F. Hoffmann-La Roche Ltd
• Werfen
• Drucker Diagnostics
• Haemonetics Corporation
• Sienco, Inc.
• BIO/DATA CORPORATION
• AggreDYNE
• Siemens Healthcare Private Limited
• Chrono-log Corporation
• Grifols, S.A.
• Helena Laboratories Corporation.
• SENTINEL.
• Sysmex Corporation
• Matis Medical Inc.
• Behnk Elektronik GmbH & Co.

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Platelet aggregation devices market in Global (2021-2030)
• Table 4: Platelet aggregation devices market in Global by Product Type (2021-2030)
• Table 5: Platelet aggregation devices market in Global by Application (2021-2030)
• Table 6: Platelet aggregation devices market in Global by End-User (2021-2030)
• Table 7: Platelet aggregation devices market in Global by Geography (2021-2030)
• Table 8: Platelet aggregation devices market in North America (2021-2030)
• Table 9: Platelet aggregation devices market in North America by Country (2021-2030)
• Table 10: Platelet aggregation devices market in the US (2021-2030)
• Table 11: Platelet aggregation devices market in Canada (2021-2030)
• Table 12: Platelet aggregation devices market in Mexico (2021-2030)
• Table 13: Platelet aggregation devices market in Europe (2021-2030)
• Table 14: Platelet aggregation devices market in Europe by Country (2021-2030)
• Table 15: Platelet aggregation devices market in France (2021-2030)
• Table 16: Platelet aggregation devices market in Germany (2021-2030)
• Table 17: Platelet aggregation devices market in the United Kingdom (2021-2030)
• Table 18: Platelet aggregation devices market in Italy (2021-2030)
• Table 19: Platelet aggregation devices market in Spain (2021-2030)
• Table 20: Platelet aggregation devices market in Russia (2021-2030)
• Table 21: Platelet aggregation devices market in Rest of Europe (2021-2030)
• Table 22: Platelet aggregation devices market in APAC (2021-2030)
• Table 23: Platelet aggregation devices market in APAC by Country (2021-2030)
• Table 24: Platelet aggregation devices market in China (2021-2030)
• Table 25: Platelet aggregation devices market in Japan (2021-2030)
• Table 26: Platelet aggregation devices market in India (2021-2030)
• Table 27: Platelet aggregation devices market in Australia (2021-2030)
• Table 28: Platelet aggregation devices market in South Korea (2021-2030)
• Table 29: Platelet aggregation devices market in Rest of APAC (2021-2030)
• Table 30: Platelet aggregation devices market in Rest of World (2021-2030)
• Table 31: Platelet aggregation devices market in RoW by Region (2021-2030)
• Table 32: Platelet aggregation devices market in Middle East (2021-2030)
• Table 33: Platelet aggregation devices market in Africa (2021-2030)
• Table 34: Platelet aggregation devices market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Platelet aggregation devices market in Global (2021-2030)
• Figure 4: Platelet aggregation devices market in Global by Product Type (2021-2030)
• Figure 5: Platelet aggregation devices market in Global by Application (2021-2030)
• Figure 6: Platelet aggregation devices market in Global by End-User (2021-2030)
• Figure 7: Platelet aggregation devices market in Global by Geography (2021-2030)
• Figure 8: Platelet aggregation devices market in North America (2021-2030)
• Figure 9: Platelet aggregation devices market in North America by Country (2021-2030)
• Figure 10: Platelet aggregation devices market in the US (2021-2030)
• Figure 11: Platelet aggregation devices market in Canada (2021-2030)
• Figure 12: Platelet aggregation devices market in Mexico (2021-2030)
• Figure 13: Platelet aggregation devices market in Europe (2021-2030)
• Figure 14: Platelet aggregation devices market in Europe by Country (2021-2030)
• Figure 15: Platelet aggregation devices market in France (2021-2030)
• Figure 16: Platelet aggregation devices market in Germany (2021-2030)
• Figure 17: Platelet aggregation devices market in the United Kingdom (2021-2030)
• Figure 18: Platelet aggregation devices market in Italy (2021-2030)
• Figure 19: Platelet aggregation devices market in Spain (2021-2030)
• Figure 20: Platelet aggregation devices market in Russia (2021-2030)
• Figure 21: Platelet aggregation devices market in Rest of Europe (2021-2030)
• Figure 22: Platelet aggregation devices market in APAC (2021-2030)
• Figure 23: Platelet aggregation devices market in APAC by Country (2021-2030)
• Figure 24: Platelet aggregation devices market in China (2021-2030)
• Figure 25: Platelet aggregation devices market in Japan (2021-2030)
• Figure 26: Platelet aggregation devices market in India (2021-2030)
• Figure 27: Platelet aggregation devices market in Australia (2021-2030)
• Figure 28: Platelet aggregation devices market in South Korea (2021-2030)
• Figure 29: Platelet aggregation devices market in Rest of APAC (2021-2030)
• Figure 30: Platelet aggregation devices market in Rest of World (2021-2030)
• Figure 31: Platelet aggregation devices market in RoW by Region (2021-2030)
• Figure 32: Platelet aggregation devices market in Middle East (2021-2030)
• Figure 33: Platelet aggregation devices market in Africa (2021-2030)
• Figure 34: Platelet aggregation devices market in South America (2021-2030)
• Figure 35: Market Drivers
• Figure 36: Market Barriers
• Figure 37: Marker Opportunities
• Figure 38: PORTER'S Five Force Analysis

Platelet Aggregation Devices Market By Product Type (Systems, Reagents, And Consumables & Accessories), By Application (Clinical Applications And Research Applications), By End-User (Hospitals, Diagnostic Laboratories, And Others) and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing number of target disorders and increasing number of research and clinical studies worldwide

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030. The platelet aggregation devices market is witnessing positive growth owing to various factors such as the rising prevalence of cardiovascular, hematological, and other target disorders and surging burden of geriatric population across the globe. Further, technological advancements in platelet aggregometers, for instance accurate and automatic testing of platelets and other advancements will increase the demand of the device in the forthcoming years. Additionally, the rise in the number of industry-academia collaborations and clinical studies in the healthcare industry will also contribute in the growth of platelet aggregation devices market. Also, the increasing regulatory approvals and launches across the globe will further increase the overall growth of the platelet aggregation devices market. Therefore, the market for platelet aggregation devices market is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Platelet Aggregation Devices Market Dynamics:

One of the main driver for the platelet aggregation devices market is the increasing figures of bleeding and haematological disorders.

For instance, the National Organization for Rare Disorders (NORD) stated in a latest study the incidence of adult Immune thrombocytopenia (ITP) in the United States was roughly estimated to be 3.3 per 100,000/year. Also, the prevalence od ITP was reported to be 9.5 per 100,000. Further, in a study done by the Maryland Health Care Commission (2023), the prevalence of ITP was estimated to be 9.5 per 100,000 children ages 1-5, 7.3 per 100,000 in children ages 6-10, and 4.1 per 100,000 in children of ages 11-14, in 2022, in the United States.

Immune thrombocytopenia (ITP) is a type of platelet disorder, whose diagnosis can be done with the help of platelet aggregation devices market. Thus, the increasing figures of ITP will increase the number of diagnosis test, ultimately rising the demand of the platelet aggregation devices market.

Further, increasing incidence of other bleeding and platelet disorder will drive the market of platelet aggregation devices market. For instance, Bernard-Soulier syndrome is a rare bleeding disorder that affects males and females in equal numbers. Recent study done by NORD suggests that Bernard Soulier syndrome affects 1 in a million people. More than 200 cases have been reported in 2022, worldwide. The detection of such syndromes can be done using platelet aggregation devices market.

Additionally, the demand for platelet aggregation systems is increasing in academic and pharmaceutical companies due to the increase in research studies, mainly to know the mechanisms involved in the interaction of platelets with vascular surfaces and evaluation and screening anti-thrombotic factors to know new targets for antiplatelet drugs. Thus, the increasing research & developmental activities and clinical trials will propel the demand of the device in the market in upcoming years.

Therefore, the factors stated above collectively will drive the overall market of platelet aggregation devices market during the forecast period from 2024-2030.

However, reduced product availability, lack of trained and skilled professionals, procedural limitations, and others, can hinder the global platelet aggregation devices market growth.

The COVID-19 pandemic has negatively impacted the market for platelet aggregation devices market. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, and others. Moreover, the number of diagnostic tests many disorders were reduced as the priority was given to the covid-19 testing. Further, due to imposition of strict lockdown rules the manufacturing of the devices was ceased. However, vaccine development of COVID-19 has produced the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services, diagnostic tests, and surgical procedures for the treatment and management of various diseases ultimately increasing the demand of platelet aggregation devices market, thereby bringing the demand for device on track in the platelet aggregation devices market.

Platelet Aggregation Devices Market Segment Analysis:

Platelet aggregation devices market by Product Type (Systems, Reagents, and Consumables & Accessories), Application (Clinical Applications and Research Applications), End-User (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the platelet aggregation devices market, the systems market is expected to have a significant revenue share in the year 2023. This was primarily owing to the application of the segment. Moreover, the advantages such as accuracy, portability, and others offered by the systems along with the increasing product launches in the market will spur the demand of the segment in the upcoming years.

The systems are specifically designed to support diagnoses of hemostasis disorders including von Willebrand Disease (vWD), Glanzmann's disease, HIT, Bernard Soulier Syndrome, Sticky Platelet Syndrome, and others. The platelet aggregation systems can also be used to precisely monitor the use of anti-platelet drugs during clinical trials or patient therapy. Moreover, the system measures the rate and extent of aggregation, agglutination, activation and inhibition reactions. Thus, the increasing prevalence of any of the above disorder can propel the demand of systems segment in the forecast period.

Further, the automated platelet aggregometry systems offer various advantages such as accuracy, reduced platelet-rich plasma volume and time, simultaneous assay and test conduction, and other advantages will increase its demand in the market.

The rising regulatory activities and launches will in turn propel the demand of the systems in the market, thereby propelling the overall growth of platelet aggregation devices market. For instance, in March 2020, Hart Bio launched ADP MEA and TRAP-6 MEA, designed to monitor and test the platelet aggregation function of patients. Both ADP MEA and TRAP-6 MEA are designed to monitor and test the platelet aggregation function of patients.

Thus, the above-mentioned factors will in turn drive the systems segment market in platelet aggregation devices market, thereby propelling the overall market growth of platelet aggregation devices market in the forecast period from 2022 - 2028.

North America is expected to dominate the overall Platelet Aggregation Devices Market:

Among all the regions, North America is expected to dominate the global platelet aggregation devices market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing number of target disorders, increasing geriatric population, technological advancements in platelet aggregometer, rising awareness among healthcare professionals regarding the benefits offered by platelet aggregation testing in disease diagnosis, and others will increase the demand for platelet aggregation devices market in North America, leading to a rise in the overall platelet aggregation devices market growth.

For instance, as per a report provided by Centers for Disease Control (CDC) in 2022, every 40 seconds, an American may have a heart attack. Platelet function tests using platelet aggregation devices market are used to monitor the antiplatelet drugs as a means to predict in cardiovascular disease. Thus, increasing prevalence of cardiovascular disorders in the North America will increase the number of platelet function test, thus leading to a higher demand for platelet aggregation devices market, which will drive the market in the North America.

Further, the increasing prevalence of bleeding and hematological disorders will shoot the demand of the device. According to the World Federation of Hemophilia 2022 report, there were about 14,816 patients with hemophilia including (Hemophilia A -11,790 and Hemophilia B-3,026) in the United States in 2020 and 3,924 patients with hemophilia in Canada in 2020 including (Hemophilia A -3,223 and Hemophilia B-701). Therefore, platelet aggregation testing is found to be very beneficial in disease diagnosis.

Additionally, factors such as the rising number of surgical procedures in this country, a large number of the population undergoing cardiovascular surgeries, increasing prevalence of orthopedic, bleeding, and urological disorders are creating high growth opportunities for the market players in the North America.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the platelet aggregation devices market.

Platelet Aggregation Devices Market Key Players:

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

Recent Developmental Activities in the Platelet Aggregation Devices Market:

In July 2022, Sysmex Corporation, a leading name in the global platelet aggregation devices marketplace, announced the launch of new automated blood coagulation analyzers. CN-3500 and CN-6500 are capable of measuring platelet aggregation parameters and blood coagulation in hemostasis and thrombosis fields.

In December 2020, Basking Biosciences Inc., a private biopharmaceutical organization, announced that it had successfully raised US$ 5.4 million in a seed financing round. The company was working on exploring the role of vWF, a redundant mediator of platelet adhesion and aggregation, to develop a reversible thrombolytic therapy for acute ischemic stroke. Rising outbreaks of dengue & malaria and growing incidence of blood cancer are also expected to drive platelet aggregation system demand in this region.

In April 2019, Aggredyne Inc. received the US FDA approval for AggreGuide A-100 ADP assay testing cartridge, an in vitro diagnostic device used for measuring various antiplatelet medications that target the platelet P2Y12 receptor.

Key Takeaways from the Platelet Aggregation Devices Market Report Study

• Market size analysis for current platelet aggregation devices market (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the platelet aggregation devices market
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global platelet aggregation devices market
• Various opportunities are available for the other competitor in the platelet aggregation devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current platelet aggregation devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for platelet aggregation devices market growth in the coming future?

Target Audience who can be benefited from this Platelet Aggregation Devices Market Report Study

• Platelet aggregation devices market providers
• Research organizations and consulting companies
• Platelet aggregation devices market -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in platelet aggregation devices market
• Various end-users who want to know more about the platelet aggregation devices market and the latest technological developments in the platelet aggregation devices market

Frequently Asked Questions for Platelet Aggregation Devices Market:

1. What are platelet aggregation devices market?

Platelet aggregation is the procedure in which the platelets are clomped together in the blood which leads to the formation of a thrombus or clot. The devices involved in the aggregation of platelets are termed as platelet aggregation devices market. The aggrometers, one of the medical device used in platelet aggregation, works against the clotting, to further stop the clot formation. This process is used for the diagnosis and identification of the defects in platelet functions.

2. What is the market for Platelet aggregation devices market?

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030.

3. What are the drivers for the platelet aggregation devices market?

The platelet aggregation devices market is observing an affirmative market growth owing to the factors such as rising prevalence of cardiovascular, haematological, and other target disorders, surging burden of geriatric population, technological advancements in platelet aggregometers, rise in the number of industry-academia collaborations and clinical studies, and the upsurge in the regulatory approvals for platelet aggregation devices market.

4. Who are the key players operating in the platelet aggregation devices market?

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

5. Which region has the highest share in platelet aggregation devices market?

North America is expected to dominate the global platelet aggregation devices market. Factors contributing to the growth are the rising number of cardiovascular surgeries, rising number of orthopaedic, urological, bleeding, and disorders, escalating burden of geriatric patients, and others which are contributing to the growth of the platelet aggregation devices market in the North America region.

Table of Contents

1.Platelet aggregation devices market Report Introduction

2.Platelet aggregation devices market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The US
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Platelet aggregation devices market Key Factors Analysis

• 4.1. Platelet aggregation devices market Drivers
  • 4.1.1. Rising prevalence of cardiovascular, hematological, and other target disorders
  • 4.1.2. Surging burden of geriatric population
  • 4.1.3. Technological advancements in platelet aggregometers
  • 4.1.4. Rise in the number of industry-academia collaborations and clinical studies
• 4.2. Platelet aggregation devices market Restraints And Challenges
  • 4.2.1. Reduced product availability
  • 4.2.2. Lack of trained and skilled professionals
  • 4.2.3. Procedural limitations
• 4.3. Platelet aggregation devices market Opportunities
  • 4.3.1. Growing adoption and market preference for automated systems among diagnostic laboratories
  • 4.3.2. Incorporation of point-of-care and miniaturized platelet aggregometers

5. Platelet aggregation devices market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Platelet aggregation devices market

7. Platelet aggregation devices market Layout

• 7.1. By Product Type
  • 7.1.1. Systems
  • 7.1.2. Reagents
  • 7.1.3. Consumables and Accessories
• 7.2. By Application
  • 7.2.1. Clinical Applications
  • 7.2.2. Research Applications
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Diagnostic Laboratories
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.1.2. Canada Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.1.3. Mexico Platelet aggregation devices market Size in USD Million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2.2. Germany Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2.3. United Kingdom Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2.4. Italy Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2.5. Spain Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2.6. Russia Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2.7. Rest of Europe Platelet aggregation devices market Size in USD Million (2021-2030)
  • 7.4.3 Asia-Pacific
    • 7.4.3.1. China Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.3.2. Japan Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.3.3. India Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.3.4. Australia Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.3.5. South Korea Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Platelet aggregation devices market Size in USD Million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.4.2. Africa Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.4.3. South America Platelet aggregation devices market Size in USD Million (2021-2030)

8. Platelet aggregation devices market Global Company Share Analysis - Key 3-5 Companies

9. Platelet aggregation devices market Company and Product Profiles

• 9.1. F. Hoffmann-La Roche Ltd
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Werfen
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Drucker Diagnostics
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Haemonetics Corporation
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Sienco, Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. BIO/DATA CORPORATION
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. AggreDYNE
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Siemens Healthcare Private Limited
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Chrono-log Corporation
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Grifols, S.A.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Helena Laboratories Corporation.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. SENTINEL.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Sysmex Corporation
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Matis Medical Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Behnk Elektronik GmbH & Co.
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us